• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

贫血与妊娠结局:一项纵向研究。

Anemia and pregnancy outcomes: a longitudinal study.

作者信息

Tunkyi K, Moodley J

机构信息

a Department of Obstetrics and Gynecology, Durban , South Africa and Women's Health and HIV Research Group, University of KwaZulu-Natal , Durban , South Africa.

出版信息

J Matern Fetal Neonatal Med. 2018 Oct;31(19):2594-2598. doi: 10.1080/14767058.2017.1349746. Epub 2017 Jul 11.

DOI:10.1080/14767058.2017.1349746
PMID:28697657
Abstract

OBJECTIVES

To determine the prevalence of anemia at the first antenatal visit and at 32-34 weeks gestational age, and to evaluate perinatal and maternal outcomes.

METHODS

Venous blood samples were obtained for complete blood counts at both study visits. Maternal and perinatal morbidity and mortality were also recorded. The data were analyzed using SPSS (version 23).

RESULTS

Two thousand pregnant women were recruited. The prevalence of anemia was 42.7% (n = 854/2000) at the first antenatal visit. Thirty-five percent had mild anemia and 68.9% had normocytic normochromic anemia. The prevalence of anemia in HIV infected women was higher than that in the noninfected group and 47.2% of the study population (n = 2000) was HIV infected. At the 32-34 weeks visit, hemoglobin (Hb) levels were available for 1433/2000 (71.7%) of the participants. The prevalence of anemia was 28.1% (n = 403/1433); 19.3% had mild anemia and 65.3% had normocytic normochromic anemia. There was a significant difference in Hb levels between that of the first visit and that at 32-34 weeks (42.7% vs. 28.1%; p = .001; 95% CI: 0.11-0.18). There were significant differences in prematurity, birth weight and hypertensive disorders of pregnancy between the anemic and nonanemic groups.

CONCLUSION

The prevalence of anemia decreased from 42.7% (booking) to 28.1% (32 - 34 weeks). Normocytic normochromic anemia was the commonest type of anemia. Attention needs to be focused on detailed investigations to establish the exact cause of anemia.

摘要

目的

确定首次产前检查时及孕32 - 34周时贫血的患病率,并评估围产期及孕产妇结局。

方法

在两次研究访视时采集静脉血样本进行全血细胞计数。同时记录孕产妇及围产期的发病率和死亡率。使用SPSS(版本23)对数据进行分析。

结果

招募了2000名孕妇。首次产前检查时贫血患病率为42.7%(n = 854/2000)。35%为轻度贫血,68.9%为正细胞正色素性贫血。HIV感染女性的贫血患病率高于未感染组,且研究人群中有47.2%(n = 2000)感染了HIV。在孕32 - 34周访视时,1433/2000(71.7%)的参与者有血红蛋白(Hb)水平数据。贫血患病率为28.1%(n = 403/1433);19.3%为轻度贫血,65.3%为正细胞正色素性贫血。首次访视时与孕32 - 34周时的Hb水平存在显著差异(42.7%对28.1%;p = 0.001;95%CI:0.11 - 0.18)。贫血组与非贫血组在早产、出生体重及妊娠高血压疾病方面存在显著差异。

结论

贫血患病率从42.7%(初诊时)降至28.1%(孕32 - 34周时)。正细胞正色素性贫血是最常见的贫血类型。需要重点关注详细调查以确定贫血的确切原因。

相似文献

1
Anemia and pregnancy outcomes: a longitudinal study.贫血与妊娠结局:一项纵向研究。
J Matern Fetal Neonatal Med. 2018 Oct;31(19):2594-2598. doi: 10.1080/14767058.2017.1349746. Epub 2017 Jul 11.
2
Prevalence of anemia in pregnant women and its effect on neonatal outcomes in Northeast India.印度东北部孕妇贫血患病率及其对新生儿结局的影响。
J Matern Fetal Neonatal Med. 2014 Jun;27(9):887-91. doi: 10.3109/14767058.2013.845161. Epub 2013 Oct 24.
3
Anaemia during pregnancy in Burkina Faso, west Africa, 1995-96: prevalence and associated factors. DITRAME Study Group.1995 - 1996年西非布基纳法索孕期贫血:患病率及相关因素。DITRAME研究组
Bull World Health Organ. 1999;77(11):916-22.
4
Maternal and Perinatal Morbidity and Mortality Associated With Anemia in Pregnancy.妊娠相关贫血与孕产妇及围生儿发病率和死亡率的关系。
Obstet Gynecol. 2019 Dec;134(6):1234-1244. doi: 10.1097/AOG.0000000000003557.
5
Effectiveness of primary level antenatal care in decreasing anemia at term in Tanzania.坦桑尼亚初级产前保健在降低足月时贫血发生率方面的有效性。
Acta Obstet Gynecol Scand. 1999 Aug;78(7):573-9.
6
Does antenatal care attendance prevent anemia in pregnancy at term?孕期按时产检能预防足月妊娠时的贫血吗?
Niger J Clin Pract. 2015 May-Jun;18(3):323-7. doi: 10.4103/1119-3077.151730.
7
Hematologic features among anemic Cameroonian pregnant women: a cross sectional study.喀麦隆贫血孕妇的血液学特征:一项横断面研究。
Pan Afr Med J. 2015 Mar 13;20:241. doi: 10.11604/pamj.2015.20.241.5253. eCollection 2015.
8
Prevalence of anaemia in pregnancy in Jima town, southwestern Ethiopia.埃塞俄比亚西南部吉马镇孕期贫血的患病率
Ethiop Med J. 1993 Oct;31(4):251-8.
9
Maternal and fetal outcome after severe anemia in pregnancy in rural Ghana.加纳农村地区孕期严重贫血后的母婴结局
Acta Obstet Gynecol Scand. 2006;85(1):49-55. doi: 10.1080/00016340500334794.
10
Anaemia in pregnancy and associated factors: a cross sectional study of antenatal attendants at the Sunyani Municipal Hospital, Ghana.孕期贫血及其相关因素:加纳苏尼亚尼市立医院产前护理人员的横断面研究
BMC Res Notes. 2017 Aug 11;10(1):402. doi: 10.1186/s13104-017-2742-2.

引用本文的文献

1
Regional variations in the trend of iron supplementation during pregnancy and its multi-level predictors in Pakistan.巴基斯坦孕期铁补充趋势的区域差异及其多层次预测因素
Sci Rep. 2025 Aug 4;15(1):28452. doi: 10.1038/s41598-025-14616-6.
2
The Potential Impact of Dietary Fiber Supplementation on Hemoglobin and Reticulocyte Hemoglobin Equivalent (RET-He) Levels in Pregnant Women with Anemia Receiving Oral Iron Therapy in Indonesia.膳食纤维补充剂对印度尼西亚接受口服铁剂治疗的贫血孕妇血红蛋白和网织红细胞血红蛋白当量(RET-He)水平的潜在影响。
J Multidiscip Healthc. 2025 Jan 17;18:183-193. doi: 10.2147/JMDH.S497795. eCollection 2025.
3
Anemia in Pregnancy: Study Phenomenology.
妊娠期贫血:研究现象学
Port J Public Health. 2023 Nov 16;42(1):6-14. doi: 10.1159/000534708. eCollection 2024 Apr.
4
The impact of different doses of oral iron supplementation during pregnancy: a pilot randomized trial.孕期不同剂量口服铁补充剂的影响:一项初步随机试验。
Blood Adv. 2024 Nov 12;8(21):5683-5694. doi: 10.1182/bloodadvances.2024013408.
5
Anaemia at mid-pregnancy is associated with prehypertension in late pregnancy among urban women.城市女性在孕中期贫血与孕晚期的妊娠高血压前期有关。
Health SA. 2024 Jun 29;29:2610. doi: 10.4102/hsag.v29i0.2610. eCollection 2024.
6
Obstetric blood transfusion in placenta previa patients with prenatal anemia: a retrospective study.前置胎盘伴产前贫血患者的产科输血:一项回顾性研究。
BMC Pregnancy Childbirth. 2024 Jan 30;24(1):92. doi: 10.1186/s12884-024-06279-4.
7
Identifying and treating iron deficiency anemia in pregnancy.识别和治疗妊娠期缺铁性贫血。
Hematology Am Soc Hematol Educ Program. 2023 Dec 8;2023(1):223-228. doi: 10.1182/hematology.2023000474.
8
Role of iron in the reduction of anemia among women of reproductive age in low-middle income countries: insights from systematic review and meta-analysis.铁在中低收入国家育龄妇女贫血减少中的作用:系统评价和荟萃分析的见解。
BMC Womens Health. 2023 Apr 17;23(1):184. doi: 10.1186/s12905-023-02291-6.
9
Improving Iron and Folic Acid Supplementation Among Pregnant Women: An Implementation Science Approach in East-Central Uganda.改善乌干达中东部孕妇的铁和叶酸补充:实施科学方法。
Glob Health Sci Pract. 2022 Dec 21;10(6). doi: 10.9745/GHSP-D-21-00426.
10
Protocol for a multicenter, double-blinded placebo-controlled randomized controlled trial comparing intravenous ferric derisomaltose to oral ferrous sulfate for the treatment of iron deficiency anemia in pregnancy: The IVIDA2 trial.多中心、双盲、安慰剂对照随机对照临床试验方案,比较静脉注射去铁胺麦芽糖铁与口服硫酸亚铁治疗妊娠期缺铁性贫血:IVIDA2 试验。
Contemp Clin Trials. 2022 Dec;123:106992. doi: 10.1016/j.cct.2022.106992. Epub 2022 Nov 8.